Ashton Thomas Private Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Ashton Thomas Private Wealth’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.3K	Sell	195 -620	-76%	-$134K	﹤0.01%	1366
2026 Q1	$164K	Buy	+815	New	+$169K	﹤0.01%	1088
2024 Q3	–	Sell	-846	Closed	-$130K	–	1020
2024 Q2	$130K	Buy	+846	New	+$127K	0.01%	685
2019 Q3	–	Sell	-3,707	Closed	-$522K	–	188
2019 Q2	$522K	Buy	3,707 +1,373	+59%	+$189K	0.2%	101
2019 Q1	$352K	Buy	+2,334	New	+$336K	0.14%	124

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Ashton Thomas Private Wealth's FBT Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 76% in Q2 2026, selling an estimated $134K and leaving 195 shares worth $48.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Ashton Thomas Private Wealth first reported a position in FBT in Q1 2019 and has held it in 5 quarters since. The position peaked at $522K in Q2 2019. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Ashton Thomas Private Wealth held 195 shares of First Trust NYSE Arca Biotechnology Index Fund worth $48.3K as of Q2 2026.
Ashton Thomas Private Wealth sold 620 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $134K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1366 holding.
Ashton Thomas Private Wealth first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 5 quarters since.
Ashton Thomas Private Wealth's First Trust NYSE Arca Biotechnology Index Fund position peaked at $522K in Q2 2019.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.